it probably involves disruption of a silencing AmiC-AmiR complex on binding of inducing amides to AmiC (Wilson The AmiC protein in Pseudomonas aeruginosa is the nega et al., 1996) . tive regulator and ligand receptor for an amide-inducible Amidase expression in the PAC1 strain of P.aeruginosa is aliphatic amidase operon. In the wild-type PAC1 strain, strongly induced by acetamide (one carbon chain) and lactamamidase expression is induced by acetamide or lactamide, ide or propionamide (two carbon chain) but not by butyramide but not by butyramide. A mutant strain of P.aeruginosa, (three carbon chain), which instead acts as an anti-inducer PAC181, was selected for its sensitivity to induction by in vivo and competes for binding to AmiC in vitro. Thus, butyramide. The molecular basis for the butyramide indulengthening of the aliphatic chain by a single carbon converts cible phenotype of P.aeruginosa PAC181 has now been a strong agonist into an antagonist. We have now cloned and determined, and results from a Thr→Asn mutation at sequenced AmiC from the PAC181 strain of P.aeruginosa, position 106 in PAC181-AmiC. In the wild-type PAC1-which was generated by classical in vivo selection for its ability AmiC protein this residue forms part of the side wall of to induce amidase expression in the presence of butyramide the amide-binding pocket but does not interact with the (Turberville and Clarke, 1981) . The crystal structure of the acetamide ligand directly. In the crystal structure of AmiC protein from this mutant strain reveals the subtle PAC181-AmiC complexed with butyramide, the Thr→Asn structural adaptation that enables the butyramide-inducible mutation increases the size of the ligand binding site such phenotype, again demonstrating the remarkable adaptability of that the mutant protein is able to close into its 'on' the 'small molecule binding protein' fold to the specific configuration even in the presence of butyramide. Although recognition of ligands. the mutation allows butyramide to be recognized as an inducer of amidase expression, the mutation is structurally Material and methods sub-optimal, and produces a significant decrease in the stability of the mutant protein.
Cloning and characterization of PAC181 amidase regulatory Keywords: crystallography/ligand specificity/mutation/protein genes evolution/small molecule binding protein
The genes amiC and amiR were amplified by PCR from PAC181 chromosomal DNA using the oligonucleotides CRA (ATCCGAATTCTCACAGGAGAGGAAACGGATG) and Introduction CRL (CCGATGCCGAAGCCTTGATGACGATACCCCTC-TT), (Genosys, Cambridge, UK) and Taq DNA polymerase. AmiC is the negative regulatory component of a 'molecular switch' which controls amide-inducible expression of the The amplified DNA fragment was isolated from a preparative agarose gel, cloned initially into pUC19 (pSW181) and characamidase operon of Pseudomonas aeruginosa . Functionally, AmiC controls the activity of a terized by restriction enzyme mapping. The 1.8 kb amiCR fragment was then subcloned into the broad host range vector transcription anti-termination factor, AmiR, which is required for transcription of the amidase operon past a ρ-independent pMMB66EH (Temple et al., 1990 ) (plasmid pSW1181) and mobilized from E.coli S17-1 into P.aeruginosa PAC327 (amiC -, terminator occurring downstream of the constitutive amidase promoter (Drew and Lowe, 1989) . In the presence of an amiR). Amidase activity was determined in intact cells under non-inducing, inducing and repressing conditions as described inducing amide, inhibition of AmiR by AmiC is relieved, and expression of amidase and other genes of the operon (including previously (Drew, 1984) and the results presented are the mean Activities are in µM acethydroxamate formed per min in a standard amidase assay (Drew, 1984) X-Ray data collection, processing and refinement Diffraction data to 2.7 Å resolution were collected at 100 K from a single PAC181-AmiC-butyramide co-crystal, cryoprotected by soaking in 1.5 M sodium citrate, 100 mM HEPESNaOH and 25% (v/v) glycerol, on a 30 cm MAR Image Plate detector mounted on a Rigaku RU200 rotating anode Xray generator. Diffraction images were integrated using the MOSFLM package (Leslie, 1995) and reduced using the SCALA, AGROVATA and TRUNCATE programs of the CCP4 Suite (CCP4, 1994). The scaled and merged data consist of 10 102 unique reflections, 97.8% complete in the range 38 to 2.7 Å (97.2% in the outer shell), with an average of 2.7 observations per reflection, and a merging R-factor of 0.098 (0.185 in the outer shell). Although the crystallization conditions for PAC181-AmiC with butyramide differ significantly from those for PAC1-AmiC with acetamide, the space group (PDB code: 1PEA) for the PAC1-AmiC-acetamide complex (Pearl et al., 1994) against the PAC181-AmiC-butyramide values of duplicate assays carried out on at least three separate complex data, using X-PLOR (Brunger, 1992) , but with occasions. One unit represents 1 µM acethydroxamate formed coordinates for the bound acetamide and solvent molecules per min. Specific activities are units per mg of bacterial cells.
omitted from the start model, and residue 106 modelled as The nucleotide sequence of the amiC and amiR genes was alanine. Difference electron density maps were calculated with determined by double-stranded sequencing using pSW181 as σA-weighted coefficients to minimize model bias (Read, 1986), template as described previously . and examined using 'O' (Jones et al., 1991) . Subsequent Identification of mutations was facilitated by running parallel simulated annealing and conjugate gradient refinement prosequencing reactions of the PAC1 amiC and amiR genes. duced the current model consisting of 370 residues, 57 solvent molecules and a butyramide ligand. The crystallographic RProtein expression and purification factor is 0.24 and the free-R factor with 5% of the data omitted The mutant AmiC protein was isolated from P.aeruginosa from refinement is 0.30. The geometric parameters of the strain PAC452 harbouring the plasmid pSW1181. Protein was model are within the ranges expected at this resolution (Lasoverexpressed and purified essentially as described (Wilson kowski et al., 1993) . Coordinates have been deposited in the et al., 1991), but with 5 mM butyramide (Sigma) present in Protein Data Bank with accession code 1QNL. the culture medium and maintained in all buffers during purification. The mutant PAC181 AmiC protein is much less CD spectroscopy easily handled than the wild type, and the omission of Near-UV circular dichroism signals were measured on a butyramide from the growth medium and isolation buffers nitrogen flushed Jasco J720 spectrapolarimeter. Measurements significantly decreased the solubility of the mutant AmiC and were made with protein concentrations of 0.4 mg/ml and prevented effective purification.
ligand concentrations of 10 mM using a 1 cm pathlength Crystallization of PAC181-AmiC-butyramide complex cuvette. The CD signal at 289 nm was measured as a function of temperature and fit to a van't Hoff equation (Freeman et al. , The solubility profile of the PAC181-AmiC protein in the 1998). The PAC1-AmiC-acetamide complex displayed a T m presence of butyramide proved to be significantly different of 84°C; the PAC1-AmiC-butyramide complex a T m of 79°C from that for the PAC1-AmiC with acetamide (Wilson et al., and the PAC181-AmiC-butyramide complex a T m of 59°C. 1991), and a new crystallization condition was identified using a sparse matrix screen (Jancarik and Kim, 1991) . Crystals of diffraction quality were eventually obtained from micro-batch Results experiments containing 12.8 mg/ml PAC181-AmiC, 5 mM Characterization of PAC181 amidase regulatory genes butyramide, 1.36 M sodium citrate and 100 mM HEPESNaOH (pH 7.5), implemented under paraffin oil in Terasaki Amidase activities were determined for P.aeruginosa strains PAC1 (wild-type), PAC181 (butyramide inducible), PAC327 dishes (Chayen et al., 1992) . the presence of lactamide or butyramide, confirming that the butyramide inducible phenotype was retained in the cloned PAC181 amiCR fragment. Nucleotide sequencing of the entire fragment revealed only a single mutation from the wild-type PAC1 sequence, a C→A transversion at position 317 in the amiC gene.
Molecular basis of butyramide inducibility of PAC181-AmiC
Earlier studies of the amidase operon had demonstrated that (Wilson et al., 1993) . Phenotypic changes in C α of threonine, which delimits the side of the ligand-binding pocket in PAC1-AmiC, provides a space for the extra two carbons of the butyramide the response to specific amides by mutant strains would aliphatic chain. Hydrogen bonds are shown as broken cylinders.
therefore be expected to be accompanied by mutations in the AmiC protein rather than in other components of the operon. The nucleotide sequence of the amiC gene from the butyramide-(amiCR -) and for PAC327 harbouring the plasmid pSW1181, which contains the 1.8 kb amiCR fragment amplified from inducible strain P.aeruginosa PAC181 revealed a single base change relative to the wild-type amiC gene sequence, resulting PAC181 (see Materials and methods). PAC1 displayed characteristic lactamide inducibility, and PAC181 displayed lactamide in the replacement of a threonine residue at 106 in the PAC1-AmiC sequence (SwissProt entry AMIC_PSEAE) with an and butyramide inducibility as previously described (Turberville and Clarke, 1981) , but with lactamide inducibility at a asparagine. As residue 106 is located close to the amide binding site at the interface of the N-and C-terminal domains lower level than in PAC1 (Table I) . Despite the regulatory negative phenotype, there is some residual background amidase of AmiC (Pearl et al., 1994) , a mutation in this residue would be consistent with a change in amide ligand specificity activity detectable in PAC327, but no induction is observed in the presence of lactamide or butyramide. PAC327 harbouring (Figure 1 ).
To define the structural effect of the Thr106→Asn mutation pSW1181 shows substantial induction of amidase activity in in PAC181, the crystal structure of PAC181-AmiC was deterreceptor, AmiC. AmiC, a member of the SMBP family, contains a widely used and adaptable ligand binding site. It appears mined in complex with butyramide. Difference Fourier maps calculated after refinement with a model in which only a C α that a single amino acid substitution in a residue close to the binding site in the AmiC of the butyramide inducible strain side chain was included for residue 106, clearly show electron density for asparagine rather than threonine (Figure 2 ), con-PAC181 is solely responsible for the new phenotype. PAC181 also contains a single residue substitution within the amidase firming the nucleotide sequence. Clear positive difference electron density is also present for a bound butyramide enzyme itself; Ser→Phe at position 7. This gives an enzyme with higher activity towards butyramide hydrolysis (Turberville molecule whose amide head group and α-carbon are in essentially identical positions to the equivalent atoms of and Clarke, 1981), although the structural basis for this remains to be determined. PAC181 thus represents a new strain able acetamide bound to PAC1-AmiC.
The mutation of Thr106→Asn removes the γ-methyl group to use butyramide, a repressor of the wild-type system, to induce expression of a new butyramide hydrolysing enzyme. of threonine, which forms part of the side wall of the amide binding pocket in PAC1-AmiC, and thereby increases the In adapting to butyramide induction via the Thr106→Asn mutation, PAC181-AmiC undergoes a significant decrease in volume of the amide-binding site. Butyramide binds to PAC181-AmiC in an unfavourable folded-over conformation its thermostability compared with wild type, and its half-life in vivo would be expected to be correspondingly shorter. in which the α and β methylene protons are eclipsed, and the γ-methyl group is in van der Waal's contact with the plane of However, the selective pressure to which the PAC181-AmiC sequence is a response, requires only that the amidase operon the amide head group. The β methylene group is in van der Waal's contact with the γ-methyl of Thr 233, and the γ-methyl be inducible by butyramide. Thus, so long as the mutant AmiC can be synthesized at a sufficient level, fold and fulfil its packs against the planes of the side chains of Asn106 and Tyr83 ( Figure 3) . biological role, its absolute structural stability need not be optimal. It is protein function that is selected in evolution, not Adaptation to binding butyramide destabilizes AmiC structural stability, a fact often neglected in theoretical analyses In the wild-type PAC1-AmiC, the side-chain γ-hydroxyl group of protein structure. of Thr106 is hydrogen bonded to the peptide oxygen of Cys82 and weakly (3.2 Å), to the side-chain amide of Gln27. The γ
